发明名称 METHOD OF PREDICTING PROGRESSION OF VIRAL HEPATITIS COURSE
摘要 FIELD: medicine. ^ SUBSTANCE: invention relates to medicine, in particular to hepatology, namely to viral hepatitis and can be used for prediction of viral hepatitis progression. Psychological testing is carried out: test MMPI, test 16-FPQ and Spielberg-Hanin test. Prognostic index is determined in form of discriminant function for patients with acute viral hepatitis by formula: CRF (chronisation risk factor) =- 0.051X1+0.241X2+0.064X3-0.041X4+0.575, where: X1 is index 1 of scale (test MMPI); X2 is index of category F (test 16-FPQ); X3 is level of situation anxiety (Spielberg-Hanin test); X4 is level of personality anxiety (Spielberg-Hanin test). If CRF is lower than -0.439 high risk of chronisation is predicted, if CRF is from 0.473 and higher - lower risk of chronisation. For patients with chronic viral hepatitis by formula: ARF (advance risk factor) =0.031X1-0.044X2-0.253X3-0.194X4+0.092X5-1.317, where: X1 is. index 1 of scale (test MMPI); X2 is index 7 of scale (test MMPI); X3 is index of category G (test 16-FPQ); X5 is level of personality anxiety (Spielberg - Hanin test) If CRF is higher than 0, high risk of hepatocirrhosis development is predicted. ^ EFFECT: increase of self-descriptiveness by detection groups with risk of process progression for taking preventive treatment measures in due time. ^ 4 ex
申请公布号 RU2416362(C2) 申请公布日期 2011.04.20
申请号 RU20090124251 申请日期 2009.06.24
申请人 GOSUDARSTVENNOE OBRAZOVATEL'NOE UCHREZHDENIE VYSSHEGO PROFESSIONAL'NOGO OBRAZOVANIJA "ALTAJSKIJ GOSUDARSTVENNYJ MEDITSINSKIJ UNIVERSITET FEDERAL'NOGOAGENTSTVA PO ZDRAVOOKHRANENIJU I SOTSIAL'NOMU RAZVITIJU" (GOU VPO AGMU ROSZDRAVA) 发明人 NIKULINA MARINA ANATOL'EVNA;LYCHEV VALERIJ GERMANOVICH;BABUSHKIN IGOR' EVGEN'EVICH
分类号 A61B5/16 主分类号 A61B5/16
代理机构 代理人
主权项
地址